[
  {
    "ts": null,
    "headline": "PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data",
    "summary": "Pulse Biosciences shares late-breaking AF data showing up to 100% procedural success, fast procedures and low adverse events for nPulse.",
    "url": "https://finnhub.io/api/news?id=cff54d87eb83785f112fbb7a7e8558e9b8efe393a41a878080a1fa2583a6dfc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770659880,
      "headline": "PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data",
      "id": 138694764,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Pulse Biosciences shares late-breaking AF data showing up to 100% procedural success, fast procedures and low adverse events for nPulse.",
      "url": "https://finnhub.io/api/news?id=cff54d87eb83785f112fbb7a7e8558e9b8efe393a41a878080a1fa2583a6dfc7"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Intuitive Surgical Stock While It's Under $500?",
    "summary": "In the past 12 months, shares of Intuitive Surgical have fallen by around 16%.",
    "url": "https://finnhub.io/api/news?id=c2d9cf05e280236f805559d8e14e7b1d572a0229f8be3dd0ac30255e9defa018",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770656700,
      "headline": "Should You Buy Intuitive Surgical Stock While It's Under $500?",
      "id": 138609849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "In the past 12 months, shares of Intuitive Surgical have fallen by around 16%.",
      "url": "https://finnhub.io/api/news?id=c2d9cf05e280236f805559d8e14e7b1d572a0229f8be3dd0ac30255e9defa018"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company Q1 Earnings Call Highlights",
    "summary": "Becton, Dickinson and Company (NYSE:BDX) reported first fiscal quarter 2026 results that management said were stronger than expected, while also highlighting the completion of its previously announced combination of its Life Sciences business with Waters through a Reverse Morris Trust transaction.",
    "url": "https://finnhub.io/api/news?id=fea69d4fd5f3b99672d35896b48dd8c2de066ce655771773d8583fb76c8e55de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770649613,
      "headline": "Becton, Dickinson and Company Q1 Earnings Call Highlights",
      "id": 138515165,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Becton, Dickinson and Company (NYSE:BDX) reported first fiscal quarter 2026 results that management said were stronger than expected, while also highlighting the completion of its previously announced combination of its Life Sciences business with Waters through a Reverse Morris Trust transaction.",
      "url": "https://finnhub.io/api/news?id=fea69d4fd5f3b99672d35896b48dd8c2de066ce655771773d8583fb76c8e55de"
    }
  }
]